Delivery Order SPE2DR25D6048-SPE2DR26FARB6
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,568.18 to Amerisourcebergen Drug Corp for the supply of Dexamethasone 120 mg/30 ml vials on January 12, 2026, with an ultimate completion date of January 13, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major...
- The Defense Logistics Agency awarded a delivery order valued at $6,930.96 to AmerisourceBergen Drug Corp for the supply of Dexamethasone 10 mg/mL vials on January 12, 2026, with an ultimate completion date of January 13, 2026. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $7,415.12 to AmerisourceBergen Drug Corp for the supply of Dexamethasone 20 mg/5 ml vials on January 7, 2026, with an ultimate completion date of January 8, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major...
- The Defense Logistics Agency awarded a delivery order valued at $1,011.64 to AmerisourceBergen Drug Corp for the supply of Dexamethasone 20 mg/5 ml vials on a firm fixed price basis. The contract, awarded December 8, 2025, with completion targeted for December 9, 2025, represents a routine pharmaceutical procurement supporting federal medical supply chain operations. This award carries no set-aside designation, indicating it was competitively awarded through open competition. The place of...
- The Defense Logistics Agency awarded a $3,457.77 firm fixed price delivery order to AmerisourceBergen Drug Corp for Dexamethasone 10 mg/mL vials, with an ultimate completion date of September 30, 2025. This non-set-aside award was made on September 29, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government, specifically...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Dexamethasone 10 mg/ml vials, with a ceiling value of $12,540.76 and a firm fixed-price structure. The award was made on January 15, 2026, with an ultimate completion date of January 16, 2026, and represents a non-set-aside, competitively awarded transaction. The place of performance is located in Conshohocken, Pennsylvania, the company's corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $2,643.44 to AmerisourceBergen Drug Corp for the supply of Dexamethasone 4 mg/mL vials, with an ultimate completion date of December 19, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $6,707.89 to AmerisourceBergen Drug Corp for the supply of Dexamethasone 10 mg/mL in vial form, with an ultimate completion date of November 26, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The work will be performed at the vendor's corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,259.53 to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Dexamethasone 4 mg/mL vials. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Dexamethasone 10 mg/ml vials valued at $1,122.52. This competitively awarded, firm fixed-price delivery order was issued on December 11, 2025, with an ultimate completion date of December 12, 2025. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support...
- SPE2DR25D6048Indefinite Delivery Contract
- SPE2DR25D6048-SPE2DR26FARB6Delivery Order
The Defense Logistics Agency awarded a $1,139.69 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Dexamethasone 120 mg/30 ml vials on January 23, 2026, with an ultimate completion date of January 26, 2026. This non-set-aside award was competitively procured and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (formerly known as AmerisourceBergen), a major pharmaceutical distributor serving federal healthcare systems. This delivery order is issued under the larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. This comprehensive IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. The DLA's Medical Supply Chain utilizes this prime vendor contract to fulfill critical pharmaceutical needs across military treatment facilities and federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 1/22/26 |